-+ 0.00%
-+ 0.00%
-+ 0.00%

SANGAMO THERAPEUTICS ADVANCES ROLLING SUBMISSION OF BLA TO U.S. FDA FOR ST-920 IN FABRY DISEASE

Reuters·03/09/2026 12:05:10

Please log in to view news